Clinical Programs

 Phase 1/2

Venadaparib in Gastric Cancer

Drug: Venadaparib

Condition: Gastric cancer

Recruitment Status: Recruiting

Contact:  info@idience.com

Location: United States, Republic of Korea, China

 Phase 1B / 2A

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

Drug: IDX-1197

Condition: Solid Tumors

Recruitment Status: Recruiting

​

Sponsor: Idience Co., Ltd.

Collaborator: IlDong Pharmaceutical Co Ltd

Contact:  info@idience.com

Location: Korea, Republic of

 Phase 1A

A Study of NOV140101 (IDX1197HCl) in Subject With Advanced Solid Tumors

Drug: IDX-1197

Condition: Advanced Solid Tumors

Recruitment Status: Recruiting

​

Sponsor: National OncoVenture

Collaborator: IlDong Pharmaceutical Co Ltd

​

Contact:  info@idience.com

Location: Korea, Republic of

 IDX-1197 Clinical Trials